Related references
Note: Only part of the references are listed.Direct medical costs of end-stage kidney disease and renal replacement therapy: a cohort study in Guangzhou City, southern China
Hui Zhang et al.
BMC HEALTH SERVICES RESEARCH (2020)
Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Boris Bikbov et al.
LANCET (2020)
Financial implications of dialysis modalities in the developing world: A Chinese perspective
Jing Liu et al.
PERITONEAL DIALYSIS INTERNATIONAL (2020)
First registry report on kidney transplantation in China
Ondrej Viklicky
TRANSPLANT INTERNATIONAL (2020)
Lifetime cost-effectiveness analysis of first-line dialysis modalities for patients with end-stage renal disease under peritoneal dialysis first policy
Carlos K. H. Wong et al.
BMC NEPHROLOGY (2020)
Global case studies for chronic kidney disease/end-stage kidney disease care
Chih-Wei Yang et al.
Kidney International Supplements (2020)
Economic evaluation of End Stage Renal Disease treatments in Iran
Amirali Moradpour et al.
CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH (2020)
Health-related quality of life and health utility of Chinese patients undergoing nocturnal home haemodialysis in comparison with other modes of dialysis
Carlos K. H. Wong et al.
NEPHROLOGY (2019)
US Renal Data System 2018 Annual Data Report: Epidemiology of Kidney Disease in the United States
Rajiv Saran et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2019)
Health-Related Quality of Life and Its Factors of Hemodialysis Patients in Suzhou, China
Chen-Wei Pan et al.
BLOOD PURIFICATION (2018)
SP682A COST AND OUTCOMES ANALYSIS OF RENAL REPLACEMENT THERAPIES USING REAL-WORLD QUALITY OF LIFE DATA
Pramod Nagaraja et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2017)
Understanding and improving the one and three times GDP per capita cost-effectiveness thresholds
Lisa A. Robinson et al.
HEALTH POLICY AND PLANNING (2017)
Changes in the worldwide epidemiology of peritoneal dialysis
Philip Kam-Tao Li et al.
NATURE REVIEWS NEPHROLOGY (2017)
The economic considerations of patients and caregivers in choice of dialysis modality
Rachael C. Walker et al.
HEMODIALYSIS INTERNATIONAL (2016)
Cost-effectiveness analysis of various strategies of end-stage renal disease patients' care in France
Isabelle Bongiovanni et al.
NEPHROLOGIE & THERAPEUTIQUE (2016)
Cost-effectiveness of haemodialysis and peritoneal dialysis for patients with end-stage renal disease in Singapore
Fan Yang et al.
NEPHROLOGY (2016)
A GLOBAL OVERVIEW OF THE IMPACT OF PERITONEAL DIALYSIS FIRST OR FAVORED POLICIES: AN OPINION
Frank Xiaoqing Liu et al.
PERITONEAL DIALYSIS INTERNATIONAL (2015)
Cost-Effectiveness of Kidney Transplantation Compared with Chronic Dialysis in End-Stage Renal Disease
Diego Rosselli et al.
SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION (2015)
Peritoneal Dialysis and In-Centre Haemodialysis: A Cost-Utility Analysis from a UK Payer Perspective
Catrin Treharne et al.
APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2014)
Design and implementation of the first nationwide, web-based Chinese Renal Data System (CNRDS)
Fengbo Xie et al.
BMC MEDICAL INFORMATICS AND DECISION MAKING (2012)
COST-EFFECTIVENESS ANALYSIS OF THE SPANISH RENAL REPLACEMENT THERAPY PROGRAM
Guillermo Villa et al.
PERITONEAL DIALYSIS INTERNATIONAL (2012)
Cost-effectiveness achieved through changing the composition of renal replacement therapy in Japan
Utako Shimizu et al.
JOURNAL OF MEDICAL ECONOMICS (2012)
Cost-effectiveness analysis of renal replacement therapy in Austria
Maria Haller et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
The cost-effectiveness of increasing kidney transplantation and home-based dialysis
Kirsten Howard et al.
NEPHROLOGY (2009)
An estimate of lifelong costs and QALYs in renal replacement therapy based on patients' life expectancy
Nick Kontodimopoulos et al.
HEALTH POLICY (2008)
Health economic evaluations: The special case of end-stage renal disease treatment
WC Winkelmayer et al.
MEDICAL DECISION MAKING (2002)
The estimation of a preference-based measure of health from the SF-36
J Brazier et al.
JOURNAL OF HEALTH ECONOMICS (2002)
Share Paper
